The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Withdrawn before enrolling
Conditions studied: Tachycardia, Ventricular, Cardiac Sudden Death
In brief
This is a prospective study to evaluating the ability of the PD2i Cardiac Analyzer to predict the risk of serious heart rhythm abnormalities in high-risk patients that do not already have an Implantable Cardioverter Defibrillator.
Key facts
- Study ID
- NCT00510731
- Run by
- Vicor Technologies, Inc.
- People needed
- 0
- Starts
- 2006-11-01
- Expected to finish
- 2009-12-01
- Last updated by the study team
- 2015-12-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age >18 years
- Left Ventricular Ejection Fraction (LVEF) <35%
- Prior myocardial infarction
- Symptomatic congestive heart failure
- Referred for EP testing and/or prophylactic ICD implantation
You may not qualify if…
- Currently has implanted pacemaker or ICD
- Current atrial fibrillation/flutter or atrial fibrillation/flutter requiring cardioversion within the previous 6 months
- Cardiac surgery or percutaneous revascularization, MI, unstable angina, or CVA within the previous 30 days
- Antiarrhythmic drug therapy other than a beta-blocker within the previous 6 months
- Previous episode of sustained VT/VF or cardiac arrest, except in the setting of acute myocardial infarction or other reversible cause
- Life expectancy of less than one year from any non-cardiac cause
- Expected cardiac transplantation within 6 months
Where it is running
- VA GLAHS - David Geffen School of Medicine at UCLA — Los Angeles, California, United States
- UCLA Medical Center — Los Angeles, California, United States
- Cardiovascular Consultants Medical Group — San Ramon, California, United States
- Cardiovascular Consultants Medical Group — Walnut Creek, California, United States
- St Francis Hospital and Medical Center, Hoffman Heart Institute — Hartford, Connecticut, United States
- Jim Moran Heart & Vascular Center — Fort Lauderdale, Florida, United States
- Florida Institute for Cardiovascular Care — Hollywood, Florida, United States
- Cardiac Disease Specialists — Atlanta, Georgia, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- VA Boston Healthcare System — West Roxbury, Massachusetts, United States
- Michigan Heart, PC — Ypsilanti, Michigan, United States
- Mid America Heart Institute / Saint Luke's Hospital — Kansas City, Missouri, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- St. Michael's Medical Center — Newark, New Jersey, United States
- Good Samaritan Hospital — Dayton, Ohio, United States
- Heart Institute of the Cascades — Bend, Oregon, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.